Zacks Small Cap Research on MSN4d
MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial…MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Compelling Results for DA-1241 in Phase 2a MASH Trial On December 18, 2024, MetaVia Inc. (NASDAQ:MTVA) announced positive topline results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback